Breaking News

Vetter Further Invests €230M in New Production Building

Ongoing investments in the supply chain for complex injectable medications aim to meet supply chain demand.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Vetter, a global CDMO, is making additional investments as part of its long-lead goals for continued expansion and to support customer needs. The company is investing €230 million in its new production building, which is currently under construction at its global corporate headquarters site in Ravensburg, Germany. The building will feature several new commercial filling lines to increase aseptic manufacturing capacity for its global customer base. Vetter plans to install the first cleanrooms by ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters